Details
You are invited to learn more about clinical strategies in Immuno-Oncology (I-O) and meet 12 Nordic Companies advancing a broad range of technologies, preclinical and clinical stage I-O assets. This event presents a special opportunity to meet, and discuss scientific and other collaboration opportunities in an informal setting.
One-page company descriptions can be downloaded here
To join, please register below.
Program:
2:00 – 2:15 pm Arrival and Welcome
2:15 – 3:30 pm Panel Discussion “Clinical Strategies for combination therapies in I-O”
- William (Bill) Slichenmyer, Alacrita (Moderator)
- Gordon Freeman, Professor, Department of Medical Oncology, Dana Farber
- David Fabrizio, Leader, Cancer Immunotherapy, Foundation Medicine
- Sridhar Ramaswamy, VP Research and Development, Tesaro
- Sotirios G. Stergiopoulos, CMO and SVP, Head of Global Medical Affairs Ipsen
3:30 – 5:00 pm Posters and Networking, Refreshments will be served.
Join this informal event and meet Senior Executives of the following companies:
Main Organizers: Oslo Cancer Cluster and Innovation Norway
Contact Norway: Jutta Heix, Oslo Cancer Cluster, jh@oslocancercluster.no; +47 94 16 30 89 and Hanne Mette Kristensen, Hanne.Mette.Dyrlie.Kristensen@innovasjonnorge.no; +47 971 97 449
Contact USA: Prem Das, premdas@alum.mit.edu; +1 (781) 248 5699
The meeting is supported by Alacrita.